BMJ  2004;328:1410 (12 June), doi:10.1136/bmj.38097.590810.7C (published 28 May 2004)

Paper

Rates of caesarean section and instrumental vaginal delivery in nulliparous women after low concentration epidural infusions or opioid analgesia: systematic review

E H C Liu, consultant1, A T H Sia, consultant2

1 Department of Anaesthesia, National University Hospital, 5 Lower Kent Ridge Road, Singapore 119074, 2 Department of Obstetric Anaesthesia, KK Women's and Children's Hospital, Singapore

Correspondence to: E H C Liu analiue{at}nus.edu.sg

Abstract

Objective To compare the effects of low concentration epidural infusions of bupivacaine with parenteral opioid analgesia on rates of caesarean section and instrumental vaginal delivery in nulliparous women.

Data sources Medline, Embase, the Cochrane controlled trials register, and handsearching of the International Journal of Obstetric Anesthesia.

Study selection Randomised controlled trials comparing low concentration epidural infusions with parenteral opioids.

Data synthesis Seven trials fulfilled the inclusion criteria for meta-analysis. Epidural analgesia does not seem to be associated with an increased risk of caesarean section (odds ratio 1.03, 95% confidence interval 0.71 to 1.48) but may be associated with an increased risk of instrumental vaginal delivery (2.11, 0.95 to 4.65). Epidural analgesia was associated with a longer second stage of labour (weighted mean difference 15.2 minutes, 2.1 to 28.2 minutes). More women randomised to receive epidural analgesia had adequate pain relief, with fewer changing to parenteral opioids than vice versa (odds ratio 0.1, 0.05 to 0.22).

Conclusions Epidural analgesia using low concentration infusions of bupivacaine is unlikely to increase the risk of caesarean section but may increase the risk of instrumental vaginal delivery. Although women receiving epidural analgesia had a longer second stage of labour, they had better pain relief.

Introduction

Although regional anaesthesia has been associated with a reduction in anaesthesia related maternal mortality, there is continuing controversy over whether epidural analgesia impedes the progress of labour by causing dystocia and increasing operative delivery rates.1-3 Previous reviews have included disparate regimens for epidural analgesia and women of mixed parity.4-6 We focused on epidural infusions containing low concentrations of local anaesthetic as these are associated with a lower risk of operative delivery.7 To overcome the confounding effect of parity, we selected nulliparous women, who have a higher risk of dystocia. We assessed all operative deliveries (caesarean section, forceps, vacuum assisted).

Methods

We searched Medline, Embase, and the Cochrane controlled trials register for all relevant clinical reports published before June 2003, using thesaurus and MeSH terms for epidural analgesia, labour, forceps, vacuum assisted delivery, caesarean section, and instrumental delivery. We searched the bibliographies of relevant studies for other reports.

We identified potentially relevant randomised controlled trials that specifically addressed whether epidural analgesia affected the risk of instrumental delivery. We then selected trials in which epidural infusions of low concentration local anaesthetic were compared with parenteral opioids and where the epidural infusions were continued during the second stage of labour.

Trial validity was assessed by using the Scottish Intercollegiate Guideline Network checklist.8 We independently assessed and scored each article and independently abstracted data in duplicate and cross checked for transcription errors and discrepancies. Trials included for meta-analysis used low concentrations of bupivacaine (≤ 0.125%) in continuous epidural infusions during the first two stages of labour in nulliparous women. All the trials had outcomes for caesarean section and instrumental vaginal delivery.

Results of the trials were combined in a meta-analysis. We used odds ratios and 95% confidence intervals for categorical outcomes and weighted mean differences for continuous outcomes. Random effects models were used for all analyses, and heterogeneity was assessed. Sensitivity analyses were carried out if there was heterogeneity in the outcome measures.

Results

Our search identified 17 potentially relevant randomised controlled trials. After exclusions, seven trials were included in the meta-analysis (see bmj.com). All seven had adequate allocation concealment. Treatment groups were similar at the start of the trials and seemed to have been treated equally. Intention to treat analyses were performed, and there were no losses to follow up. In none of the trials were the patients or investigators blinded.

These seven trials used low concentration bupivacaine infusions (0.125% or 0.0625%) but varied in the addition of opioids. They included only women with full term uncomplicated pregnancies with cephalic presentation. One trial included patients in spontaneous or induced labour, with separate data for those in spontaneous labour.

Quantitative data analysis
Caesarean section
Data were analysed for 2962 nulliparous women. Rates of caesarean section did not differ between women receiving epidural analgesia and those receiving parenteral opioids (odds ratio 1.03, 95% confidence interval 0.71 to 1.48; fig 1). One trial showed a greatly increased risk of caesarean section with epidural analgesia. This small trial caused heterogeneity in the meta-analysis; when we excluded it from sensitivity analysis, the risk was slightly changed (1.01, 0.80 to 1.28), and there was no heterogeneity. Separate analyses of caesarean section rates for dystocia and for fetal distress also showed no significant differences (1.00 (0.64 to 1.58) and 1.15 (0.79 to 1.67) respectively). Analysis including only women in spontaneous labour also showed no significant difference (1.08, 0.65 to 1.82).



View larger version (32K):
[in this window]
[in a new window]
 
Fig 1 Rates of caesarean section in trials of nulliparous women receiving epidural analgesia or parenteral opioids

 

Other maternal outcomes
Rates of instrumental vaginal delivery were higher with epidural analgesia (1.63, 1.12 to 2.37); however, two trials included elective forceps delivery and forceps deliveries for training purposes, and two other trials included women who had their labour induced. When we excluded these, the risk was higher but not significant (2.11, 0.96 to 4.65; fig 2). Total operative delivery was more likely with epidural analgesia (1.63, 1.09 to 2.42). This risk was slightly reduced when we excluded the two trials with elective forceps deliveries and with forceps deliveries for training purposes (1.55, 1.03 to 2.32). Epidural analgesia was associated with a longer second stage of labour (weighted mean difference 15.2 minutes, 2.1 to 28.2 minutes). Non-compliance with allocated analgesia was much less with epidural analgesia (0.19, 0.11 to 0.33). Fewer women changed from the epidural group to the opioid group than vice versa (0.10, 0.05 to 0.22).



View larger version (21K):
[in this window]
[in a new window]
 
Fig 2 Rates of instrumental vaginal delivery and odds ratios in trials of nulliparous women receiving epidural analgesia or parenteral opioids; trials were excluded when elective forceps were permitted or where labour was induced

 

Neonatal outcomes
Fewer neonates in the epidural groups had Apgar scores of less than 7 at five minutes and umbilical artery pHs of less than 7.2, but these differences were not statistically significant (0.72 (0.26 to 2.04) and 0.72 (0.40 to 1.27) respectively). Although only two trials provided data on requirement of nalaxone by neonates, it was lower in neonates whose mothers had had epidural analgesia (0.1, 0.01 to 0.89).

Discussion

Nulliparous women who receive epidural analgesia during labour do not seem to be at an increased risk of delivery by caesarean section; the wide confidence intervals introduce some uncertainty. Epidural analgesia may be associated with a higher risk of instrumental vaginal delivery. Although epidural analgesia was associated with a longer second stage of labour, neonates seemed unharmed. We found no worsening of Apgar scores or umbilical acid-base status in neonates whose mothers had received epidural analgesia, despite the increased risk of instrumental vaginal delivery. These neonates were also less likely to need naloxone than neonates whose mothers received opioid analgesia.

One limitation of these trials is the disparity in the quality of pain relief between epidural analgesia and parenteral opioids, which would have made blinding of clinicians difficult. Bias may have been present owing to a lower threshold for performing instrumental vaginal delivery in the presence of epidural analgesia. Differences in protocols for management of labour could have contributed to the differences in rates of instrumental vaginal delivery.


What is already known on this topic

Epidural analgesia during labour is effective but has been associated with increased rates of instrumental delivery

Studies have included women of mixed parity and high concentrations of epidural anaesthetic

What this study adds

Epidural infusions with low concentrations of local anaesthetic are unlikely to increase the risk of caesarean section in nulliparous women

Although epidural analgesia is associated with an increased risk of instrumental vaginal delivery, operator bias cannot be excluded

Epidural analgesia is associated with a longer second stage labour and increased oxytocin requirement, but the importance of these is unclear as maternal analgesia and neonatal outcome may be better with epidural analgesia


Another limitation was the large number of women who changed from parenteral opioids to epidural analgesia. Our intention to treat approach would likely render any estimation of the effects of epidural analgesia more conservative, but it was necessary to prevent selection bias. Comparing a policy of offering epidural analgesia with one of offering parenteral opioids reflects real life. As the definitions of stages of labour varied between trials, we were unable to determine if epidural analgesia prolonged the first stage, and the actual duration can only be estimated. Unlike previous reviews, we focused on nulliparous women because the indications for, and risks of, caesarean section differ with parity.

We limited our analysis to trials that used infusions of bupivacaine with concentrations of 0.125% or less, to reflect current practice. In a randomised controlled trial, low concentrations have been shown to reduce the rate of instrumental delivery.7

Epidural analgesia may increase the risk of instrumental delivery by several mechanisms. Reduction of serum oxytocin levels can result in a weakening of uterine activity.9 10 This may be due in part to intravenous fluid infusions being given before epidural analgesia, reducing oxytocin secretion.11 The increased use of oxytocin after starting epidural analgesia may indicate attempts at speeding up labour. Maternal efforts at expulsion can also be impaired, causing fetal malposition during descent.12 Previously, the association of neonatal morbidity and mortality with longer labour (second stage longer than two hours) had justified expediting delivery, leading to increased rates of instrumental delivery.13

Delaying pushing until the fetus's head is visible or until one hour after reaching full cervical dilation may reduce the incidence of instrumental delivery and its attendant morbidity.13 Although women receiving epidural analgesia had a longer second stage labour, this was not associated with poorer neonatal outcome in our analysis.


This is the abridged version of an article that was posted on bmj.com on 28 May 2004: http://bmj.com/cgi/doi/10.1136/bmj.38097.590810.7C

We thank Christopher R Palmer (University of Cambridge) for guiding us and Shiv Sharma (University of Texas Southwestern Medical Centre) for helping with the data.

Contributors: See bmj.com

Funding: None.

Competing interests: None declared.

Ethical approval: Not required.

References

  1. Hawkins JL, Koonin LM, Palmer SK, Gibbs CP. Anesthesia-related deaths during obstetric delivery in the United States, 1979-1990. Anesthesiology 1997;86: 277-84.[Web of Science][Medline]
  2. Chestnut DH. Anesthesia and maternal mortality. Anesthesiology 1997;86: 273-6.[CrossRef][Web of Science][Medline]
  3. Roberts CL, Algert CS, Douglas I, Tracy SK, Peat B. Trends in labour and birth interventions among low-risk women in New South Wales. Aust NZ J Obstet Gynaecol 2002;42: 176-81.[CrossRef][Web of Science][Medline]
  4. Halpern SH, Leighton BL, Ohlsson A, Barrett JF, Rice A. Effect of epidural vs parenteral opioid analgesia on the progress of labor: a meta-analysis. JAMA 1998;280: 2105-10.[Abstract/Free Full Text]
  5. Zhang J, Klebanoff MA, DerSimonian R. Epidural analgesia in association with duration of labor and mode of delivery: a quantitative review. Am J Obstet Gynecol 1999;180: 970-7.[CrossRef][Web of Science][Medline]
  6. Howell CJ. Epidural versus non-epidural analgesia for pain relief in labour. Cochrane Database Syst Rev 2000; CD000331.
  7. Comparative Obstetric Mobile Epidural Trial (COMET) Study Group UK. Effect of low-dose mobile versus traditional epidural techniques on mode of delivery: a randomised controlled trial. Lancet 2001;358: 19-23.[CrossRef][Web of Science][Medline]
  8. Scottish Intercollegiate Guidelines Network. Methodology checklist 2: randomised controlled trials. www.sign.ac.uk/guidelines/fulltext/50/checklist2.html (accessed 7 Mar 2004).
  9. Goodfellow CF, Hull MG, Swaab DF, Dogterom J, Buijs RM. Oxytocin deficiency at delivery with epidural analgesia. Br J Obstet Gynaecol 1983;90: 214-9.[Web of Science][Medline]
  10. Bates RG, Helm CW, Duncan A, Edmonds DK. Uterine activity in the second stage of labour and the effect of epidural analgesia. Br J Obstet Gynaecol 1985;92: 1246-50.[Web of Science][Medline]
  11. Cheek TG, Samuels P, Miller F, Tobin M, Gutsche BB. Normal saline i.v. fluid load decreases uterine activity in active labour. Br J Anaesth 1996;77: 632-5.[Abstract/Free Full Text]
  12. Newton ER, Schroeder BC, Knape KG, Bennett BL. Epidural analgesia and uterine function. Obstet Gynecol 1995;85: 749-55.[CrossRef][Web of Science][Medline]
  13. Miller AC. The effects of epidural analgesia on uterine activity and labor. Int J Obstet Anesth 1997:6: 2-18.
(Accepted 18 March 2004)


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Good news is often ignored
Felicity Reynolds
BMJ 2004 329: 293. [Extract] [Full Text]

Epidural analgesia does not increase risk of caesarean intervention
BMJ 2004 328: 0. [Full Text]

Do mistakes matter?
Kamran Abbasi
BMJ 2004 328: 0. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • (2004). 23 Apr 2004 to 23 Jul 2004. Evid. Based Nurs. 7: e4-e4 [Full text]  
  • (2004). Other articles noted. Evid. Based Med. 9: e5-e5 [Full text]  
  • Reynolds, F. (2004). Good news is often ignored. BMJ 329: 293-293 [Full text]  
  • (2004). Epidural Analgesia During Labor Doesn't Increase Risk for Cesarean Section. JWatch General 2004: 3-3 [Full text]  

Rapid Responses:

Read all Rapid Responses

Good news is often ignored
FELICITY REYNOLDS
bmj.com, 20 Jun 2004 [Full text]
Epidurals need more monitoring
Hitesh Patel, et al.
bmj.com, 23 Jun 2004 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ